Clinical Study| Volume 16, ISSUE 4, P482-490, April 2016

Download started.


Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS)

Published:September 24, 2015DOI:


      Background Context

      The New England Spinal Metastasis Score (NESMS) was recently proposed to help predict 1-year survival following surgery for spinal metastases. Its ability to predict short-term outcomes, including 30-day morbidity, mortality, and hospital length of stay, has not been evaluated.


      Assess the capacity of NESMS to predict 30-day morbidity and mortality, as well as hospital length of stay, following surgery for spinal metastases.

      Study Design

      Validation study.

      Patient Sample

      All patients who had undergone spinal surgery with a history of metastatic spinal disease within the National Surgical Quality Improvement Program (NSQIP; 2007–2013).

      Outcome Measure

      Mortality, complications, failure to rescue, and length of stay.


      Demographic, oncologic, laboratory, and surgical data were obtained from the NSQIP. All patients were assigned an NESMS score (0–3). The effect of the NESMS score on the outcomes of interest was assessed using multivariable logistic regression and negative binomial regression that controlled for confounders. Final model discrimination and calibration were assessed using the c-statistic and Hosmer-Lemeshow test, respectively. Internal validation was performed using a bootstrapping procedure.


      NSQIP data on 776 patients were included in this analysis. The 30-day mortality rate was 11% (N=87), and 51% of patients (N=395) sustained one or more complications. The final adjusted model demonstrated that the NESMS was a statistically significant predictor of 30-day mortality (p<.001), major systemic complications (p<.001), and failure to rescue (p=.03) following metastatic spinal surgery. Patients with an NESMS score of 3 had an 89% reduction in mortality (95% confidence interval [CI]: 0.04, 0.31), a 74% reduction in major systemic complications (95% CI: 0.11, 0.62), and an 88% reduction in failure to rescue (95% CI: 0.03, 0.47) as compared with those with a score of 0. The final model explained 71% of the variation in 30-day mortality. Findings were unchanged in the bootstrap analysis performed among 77,600 patient replicates.


      This study demonstrates the clinical accuracy of the NESMS score for predicting short-term major morbidity and mortality following metastatic spinal surgery. The success of this score in an independent cohort of patients collected from centers across the United States indicates its potential for translation to clinical practice.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Spine Journal
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kim J.M.
        • Losina E.
        • Bono C.M.
        • Schoenfeld A.J.
        • Collins J.E.
        • Katz J.N.
        • et al.
        Clinical outcome of metastatic spinal cord compression treated with surgical excision ± radiation versus radiation therapy alone: a systematic review of literature.
        Spine. 2012; 37: 78-84
        • Arrigo R.T.
        • Kalanithi P.
        • Cheng I.
        • Alamin T.
        • Carragee E.J.
        • Mindea S.A.
        • et al.
        Charlson score is a robust predictor of 30-day complications following spinal metastasis surgery.
        Spine. 2011; 36: E1274-80
        • Tatsui C.E.
        • Suki D.
        • Rao G.
        • Kim S.S.
        • Salaskar A.
        • Hatiboglu M.A.
        • et al.
        Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma.
        J Neurosurg Spine. 2014; 20: 108-116
        • Lau D.
        • Leach M.R.
        • Than K.D.
        • Ziewacz J.
        • La Marca F.
        • Park P.
        Independent predictors of complication following surgery for spinal metastasis.
        Eur Spine J. 2013; 22: 1402-1407
        • Lee B.H.
        • Park J.O.
        • Kim H.S.
        • Park Y.C.
        • Lee H.M.
        • Moon S.H.
        Perioperative complication and surgical outcome in patients with spine metastases: retrospective 200-case series in a single institute.
        Clin Neurol Neurosurg. 2014; 122: 80-86
        • Kim C.H.
        • Chung C.K.
        • Jahng T.A.
        • Kim H.J.
        Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis.
        Spine J. 2011; 11: 1015-1023
        • Ghori A.K.
        • Leonard D.A.
        • Schoenfeld A.J.
        • Saadat E.
        • Scott N.
        • Ferrone M.L.
        • et al.
        Modeling one-year survival after surgery on the metastatic spine.
        Spine J. 2015; (E-pub ahead of print)
        • Quraishi N.A.
        • Rajabian A.
        • Sepncer A.
        • et al.
        Reoperation rates in the surgical treatment of spinal metastases.
        Spine J. 2015; 15: 37S-43
        • Quraishi N.A.
        • Manoharan S.R.
        • Arealis G.
        • Khurana A.
        • Elsayed S.
        • Edwards K.L.
        • et al.
        Accuracy of the revised Tokuhashi score in predicting survival in patients with metastatic spinal cord compression (MSCC).
        Eur Spine J. 2013; 22: S21-6
        • Bollen L.
        • de Ruiter G.C.
        • Pondaag W.
        • Arts M.P.
        • Fiocco M.
        • Hazen T.J.
        • et al.
        Risk factors for survival of 106 surgically treated patients with symptomatic spinal epidural metastases.
        Eur Spine J. 2013; 22: 1408-1416
        • Holman P.J.
        • Suki D.
        • McCutcheon I.
        • Wolinsky J.P.
        • Rhines L.D.
        • Gokaslan Z.L.
        Surgical management of metastatic disease of the lumbar spine: experience with 139 patients.
        J Neurosurg Spine. 2005; 2: 550-563
        • Dea N.
        • Versteeg A.
        • Fisher C.
        • Kelly A.
        • Hartig D.
        • Boy M.
        • et al.
        Adverse events in emergency oncological spine surgery: a prospective analysis.
        J Neurosurg Spine. 2014; 21: 698-703
        • Tabouret E.
        • Cauvin C.
        • Funetes S.
        • et al.
        Reassessment of scoring systems and prognostic factors for metastatic spinal cord compression.
        Spine J. 2015; 15: 944-950
        • Schoenfeld A.J.
        • Carey P.A.
        • Cleveland III, A.W.
        • Bader J.O.
        • Bono C.M.
        Patient factors, co-morbidities and surgical characteristics that increase mortality and complication-risk following spinal arthrodesis: a prognostic study based on 5,887 patients.
        Spine J. 2013; 10: 1171-1179
        • Belmont Jr, P.J.
        • Davey S.
        • Orr J.D.
        • Ochoa L.M.
        • Bader J.O.
        • Schoenfeld A.J.
        Risk factors for 30-day post-operative complications and mortality after below-knee amputation: a study of 2,911 patients from the National Surgical Quality Improvement Program.
        J Am Coll Surg. 2011; 213: 370-378
        • Schoenfeld A.J.
        • Ochoa L.M.
        • Bader J.O.
        • Belmont Jr, P.J.
        Risk factors for immediate postoperative complications and mortality following spine surgery: a study of 3475 patients from the National Surgical Quality Improvement Program.
        J Bone Joint Surg Am. 2011; 93: 1577-1582
        • Schoenfeld A.J.
        • Serrano J.A.
        • Waterman B.R.
        • Bader J.O.
        • Belmont Jr, P.J.
        The impact of resident involvement on post-operative morbidity and mortality following orthopaedic procedures: a study of 43,343 cases.
        Arch Orthop Trauma Surg. 2013; 133: 1483-1491
        • Belmont Jr, P.J.
        • Goodman G.P.
        • Hamilton W.
        • Waterman B.R.
        • Bader J.O.
        • Schoenfeld A.J.
        Morbidity and mortality in the thirty-day period following total hip arthroplasty: risk factors and incidence.
        J Arthroplasty. 2014; 29: 2025-2030
        • Waterman B.R.
        • Dunn J.C.
        • Bader J.
        • Urrea L.
        • Schoenfeld A.J.
        • Belmont Jr, P.J.
        Thirty-day morbidity and mortality after elective total shoulder arthroplasty: patient-based and surgical risk factors.
        J Shoulder Elbow Surg. 2015; 24: 24-30
        • Schoenfeld A.J.
        Evaluating perioperative outcomes and efficiency following total joint arthroplasty in the U.S. and Canada: a tale of two systems?.
        JAMA Surg. 2015; (E-pub ahead of print)
        • Pugely A.J.
        • Martin C.T.
        • Gao Y.
        • Klocke N.F.
        • Callaghan J.J.
        • Marsh J.L.
        A risk calculator for short-term morbidity and mortality after hip fracture surgery.
        J Orthop Trauma. 2014; 28: 63-69
        • Martin C.T.
        • Pugely A.J.
        • Gao Y.
        • Wolf B.R.
        Risk factors for thirty-day morbidity and mortality following knee arthroscopy: a review of 12,271 patients from the national surgical quality improvement program database.
        J Bone Joint Surg Am. 2013; 95: e98
        • Bauer H.C.
        • Wedin R.
        Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients.
        Acta Orthop Scand. 1995; 66: 143-146
        • Long J.S.
        • Freese J.
        Regression models for categorical dependent variables using Stata.
        2nd ed. Stata Press, College Station, TX2006
        • Collins G.S.
        • Reitsma J.B.
        • Altman D.G.
        • Moons K.G.
        Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.
        Ann Intern Med. 2015; 162: 55-63
        • Tomita K.
        • Kawahara N.
        • Kobayashi T.
        • Yoshida A.
        • Murakami H.
        • Akamaru T.
        Surgical strategy for spinal metastases.
        Spine. 2001; 26: 298-306
        • Tokuhashi Y.
        • Matsuzaki H.
        • Toriyama S.
        • Kawano H.
        • Ohsaka S.
        Scoring system for the preoperative evaluation of metastatic spine tumor prognosis.
        Spine. 1990; 15: 1110-1113